{"schema_version":"secwatch.filing_event.v1","accession":"0000012208-22-000040","form_type":"8-K","ticker":"BIO","cik":"0000012208","company_name":"BIO-RAD LABORATORIES, INC.","filed_at":"2022-07-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.163932+00:00","generated_at":"2026-06-24T07:19:12.125066+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Bio-Rad Q2 revenue $691M down 3.5% YoY; non-GAAP EPS $3.38; raises FY22 revenue outlook; adds $200M buyback","bullets":["Q2 GAAP net loss $927M ($31.12/diluted) vs income $914M ($30.32) last year; non-GAAP net income $101M ($3.38) vs $107M ($3.54).","Reported sales $691.1M down 3.5% YoY; currency-neutral core sales (ex-COVID) up 5.7%.","Life Science $322M (-3.5% reported, +0.5% constant); Clinical Diag $368M (-3.3%, +0.7% constant).","FY22 guidance: non-GAAP currency-neutral revenue growth at high end of 1-2%; COVID rev ~$93M (up); op margin ~19% reaffirmed.","Board authorized additional $200M share repurchase; total available $298.1M."],"urls":{"canonical":"https://secwatch.observer/filing/0000012208-22-000040","json":"https://secwatch.observer/filing/0000012208-22-000040.json","markdown":"https://secwatch.observer/filing/0000012208-22-000040.md","text":"https://secwatch.observer/filing/0000012208-22-000040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/12208/000001220822000040/0000012208-22-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/12208/000001220822000040/bio-20220728.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T07:19:12.125066+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}